Mechanisms, markers and management of hypercoagulable states

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Information on hypercoagulability can be achieved through the measurement of peptides that are generated when zymogens are activated, of the active enzymes, or of the complexes that form in the circulation when enzymes are inactivated by their plasmatic inhibitors. These assay methods have dramatically improved our understanding of the mechanisms which regulate coagulation in health and disease. However, their choice and use as predictors of thrombotic events and to monitor anticoagulant treatment still need to be defined in prospective clinical trials.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalHaemostasis
Volume26
Issue numberSUPPL. 4
Publication statusPublished - Oct 1996

Fingerprint

Enzyme Precursors
Thrombophilia
Enzymes
Anticoagulants
Clinical Trials
Peptides
Health

Keywords

  • d-dimer
  • F1+2
  • hypercoagulable states
  • thrombophilia

ASJC Scopus subject areas

  • Hematology

Cite this

Mechanisms, markers and management of hypercoagulable states. / Mannuci, Pier Mannuccio; Tripodi, Armando.

In: Haemostasis, Vol. 26, No. SUPPL. 4, 10.1996, p. 1-8.

Research output: Contribution to journalArticle

@article{c5b822d5dfc043dda1cac7ad908a2838,
title = "Mechanisms, markers and management of hypercoagulable states",
abstract = "Information on hypercoagulability can be achieved through the measurement of peptides that are generated when zymogens are activated, of the active enzymes, or of the complexes that form in the circulation when enzymes are inactivated by their plasmatic inhibitors. These assay methods have dramatically improved our understanding of the mechanisms which regulate coagulation in health and disease. However, their choice and use as predictors of thrombotic events and to monitor anticoagulant treatment still need to be defined in prospective clinical trials.",
keywords = "d-dimer, F1+2, hypercoagulable states, thrombophilia",
author = "Mannuci, {Pier Mannuccio} and Armando Tripodi",
year = "1996",
month = "10",
language = "English",
volume = "26",
pages = "1--8",
journal = "Haemostasis",
issn = "0301-0147",
publisher = "S. Karger AG",
number = "SUPPL. 4",

}

TY - JOUR

T1 - Mechanisms, markers and management of hypercoagulable states

AU - Mannuci, Pier Mannuccio

AU - Tripodi, Armando

PY - 1996/10

Y1 - 1996/10

N2 - Information on hypercoagulability can be achieved through the measurement of peptides that are generated when zymogens are activated, of the active enzymes, or of the complexes that form in the circulation when enzymes are inactivated by their plasmatic inhibitors. These assay methods have dramatically improved our understanding of the mechanisms which regulate coagulation in health and disease. However, their choice and use as predictors of thrombotic events and to monitor anticoagulant treatment still need to be defined in prospective clinical trials.

AB - Information on hypercoagulability can be achieved through the measurement of peptides that are generated when zymogens are activated, of the active enzymes, or of the complexes that form in the circulation when enzymes are inactivated by their plasmatic inhibitors. These assay methods have dramatically improved our understanding of the mechanisms which regulate coagulation in health and disease. However, their choice and use as predictors of thrombotic events and to monitor anticoagulant treatment still need to be defined in prospective clinical trials.

KW - d-dimer

KW - F1+2

KW - hypercoagulable states

KW - thrombophilia

UR - http://www.scopus.com/inward/record.url?scp=0029960580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029960580&partnerID=8YFLogxK

M3 - Article

C2 - 8979106

AN - SCOPUS:0029960580

VL - 26

SP - 1

EP - 8

JO - Haemostasis

JF - Haemostasis

SN - 0301-0147

IS - SUPPL. 4

ER -